RNA delivery is moving from breakthrough to backbone. This review examines how LNPs and emerging carriers are reshaping scalability, targeting, manufacturing, and real-world deployment of RNA therapeutics.
- In Vivo's Biggest Threat — Comparison To Old Models
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Conducting A Medical Device Stability Study: A Practical Guide
- Nanotechnology Drug Delivery: A Market Overview
- Combination: The Drug Delivery Word Of The Year For 2026
- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
- Electronic Drug Delivery Devices Market: Advancing Smart, Connected Healthcare
- Regulating For Patient Safety And Success With Combination Products
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Solid Form Screening, Rapid Formulation Selection To Meet Tight Timelines
A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.
-
Biodegradable Polymers For Parenteral Drug Delivery
Long-acting, complex drug delivery products, particularly those based on injectable microparticles, nanoparticles, and implants, are among the most attractive parenteral products.
-
Lyophilization vs. Liquid Formation: Why Lyo Offers Advantages
Lyophilization offers some alluring advantages in today’s complex market, but its challenges require innovation and expertise to surmount.
-
How To Leverage Modeling And Simulation In The Candidate Development Stage
Modeling and simulation provides another way to predict the clinical performance of a molecule, based on a robust and holistic approach, before investing the required time and money.
-
Single Source Partner: Seamless Approach To Deliver World-Class Treatment
Growing demand for high-value, complex therapies requires the right containment and delivery systems: solutions that offer superior quality and patient comfort while meeting stringent regulatory requirements.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
-
A Taste Masked And Easily Swallowed Malaria Drug For Elderly Patients
Dysphagia impacts treatment compliance and disproportionately affects the elderly. Learn how microencapsulation enabled formulation of a water-soluble powder drives patient adherence.
-
Vial Adapter Considerations For Cell And Gene Therapy Applications
Review features that need to be considered to choose a vial adapter for cell and gene therapy drug products and a case study where vial adapter transfer devices have been used to extract lentiviruses.
-
High-Throughput Platform Propels Gene Editing Therapy Research
Explore the potential of polymeric nanoparticles (PNPs) as an alternative to viral vectors. PNPs offer design flexibility, enabling larger payloads, targeted release, and minimized side effects.
-
Key Considerations For Selecting Flexible Fillers
Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
4 Opportunities For Advancing Drug Delivery
In this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies.

